Women As One partners with industry organizations around the world in support of their gender diversity, equity, and inclusion goals, offering tailored solutions for their needs.
Organizations often want to support gender-diverse opportunities but aren’t always sure how to find the right candidates. With nearly 3,000 cardiologists from over 100 countries registered in our Talent Directory, Women As One has unprecedented access to the professional credentials, experiences and preferences of women actively seeking their next professional milestone. Work with us to find qualified candidates for jobs, speaking engagements, advisory boards, clinical trial leadership and more.
As Novartis grows, so does their commitment to including the voices of women in cardiology. Whether they are looking for thought leaders or need clinical trial leadership positions filled, Novartis is committed to women’s representation.
When they needed to identify thought leaders among extremely specific disease states, it was hard to imagine where they could easily find detailed expertise through their current contact vendors. So, Novartis asked us to connect them with women cardiologists who fit the bill.
Novartis gave Women As One a detailed report on what they were looking for in new connections: women in cardiology, proceduralists, experts in PAD and plaque, among other specific disease states. They were hoping to find women who had experience in these areas clinically but also through guideline committee participation and publication expertise.
There’s no question that this level of detail was a high bar to meet – but we were more than up to the challenge. Women As One got to work using our Talent Directory and other survey and programming data to deliver detailed profiles to Novartis.
We ultimately delivered 125 contacts specifically curated to meet the criteria Novartis asked for. Women As One recently met with the Novartis team in-person to review and discuss outreach plans for these profiles and other ways that we could support their though leader engagement strategy.
We are proud to be a Women As One industry partner, and utilization of their Talent Directory is just one way that we are able to ensure we have representation of female voices and ideas across all levels and areas of practice to conceptualize and execute all our initiatives in cardiology.
Cheryl Abbas, PharmD, FAHA
US Medical Team Head, ASCVD at Novartis
Women As One has established the world’s most robust community of women cardiologists. We continuously engage with our community to source their feedback and promote their unique expertise. We also partner with organizations to put this powerful knowledge base into action through in-depth consulting services, ensuring you receive the best advice from the most qualified experts.
Our consulting services range widely in their utility, from the simple to the complex. They include activities such as focus group orchestration, clinical trial design, marketing copy review and feedback, and recruitment strategy support.
As an approved co-sponsor of your next event or activity, Women As One will support your promotional plan in alignment with our mission. We can help you reach your target audience through our digital channels, lending you our trusted brand and community support. We can also support faculty selection and curriculum development, allowing you to tap into the qualified expertise of the Women As One Talent Directory.
When Esperion completed its CLEAR Outcomes study, they were thrilled to have enrolled 48% women. As most trials enroll fewer than 30% women, Esperion wanted to celebrate this achievement and understand how they could continue to set the bar higher for clinical trial enrollment diversity. When they reached out to Women As One and expressed their interest in holding a forum for discussion, we not only agreed – we enthusiastically said, “Yes!”
We sat down with Esperion and ideated the event details: a networking reception featuring a panel discussion on the results from CLEAR and barriers and opportunities for enrolling more women into clinical trials that would take place during the 2024 American College of Cardiology Annual Scientific Sessions.
Esperion also wanted to create a keepsake publication, “The Pulse of Change, Women in Cardiology ” which would showcase the history of women in cardiology linked to the opportunity to improve gender disparities in cardiovascular care and research.
With the event planned, we got to work identifying and securing experts on diversity in clinical trial enrollment and promoted the event to our community of women physicians. We also collaborated with content and design experts to create the keepsake book.
As Esperion showed the results of their CLEAR Outcomes study to women cardiologists from around the globe in conjunction with the launch of “The Pulse of Change”, we watched as history was made and honored.
Over 100 women and allies showed up to celebrate the success of CLEAR and discuss ways to forge new standards for the enrollment of women in clinical trials. Dr. Michael Gibson, whose artwork was featured in “The Pulse of Change” was also on hand to sign copies of the book!
Esperion gained actionable insights about advancing gender diversity in clinical trial enrollment and leadership and Women As One helped to showcase Esperion as an important leader in research equity.
Women As One staff can work with your organization to execute high-quality event delivery. With experienced staff, we provide cost-effective event services from venue selection to marketing and promotion to on-site and virtual delivery and post-program evaluation. We’ll work hand-in-hand with you to create a meaningful experience for our shared communities.
Abbott Vascular was looking to connect with women cardiologists at the 2023 ESC Congress in Amsterdam. Their aim was two-fold: have honest conversations about what it’s like to be a woman cardiologist in Europe and engage with current and future thought leaders for ongoing collaborative opportunities. As a US-based company, they approached Women As One as a partner in reaching their goals.
Women As One got to work curating a panel discussion with Abbott on leadership in cardiology. We also sourced a venue at the congress center, managed marketing and registration and provided all on-site logistics support. With over 2,600 women cardiologists involved with Women As One, we contacted our Talent Directory registrants to encourage those who would be interested in contributing to the discussion to attend.
The panel was a mix of men and women leaders in the field and featured a special presentation from Ukranian cardiologist Oksana Marchenko, a past Women As One CLIMB program participant, about her work to support displaced Ukranian physicians in the UK.
The event drew over 200 attendees, and the atmosphere was charged with excitement. Abbott gained access to established and new voices in the field, building groundwork for future collaborations, and together taking a step toward a more inclusive future for women across the globe.We worked with Abbott to build global relationships through a panel discussion at ESC Congress 2023.
The collaboration with Women As One at the ESC Congress allowed us to directly meet with global cardiologists in a meaningful way. Leadership is a universal trait that many women cardiologists are seeking to further their development, that’s why Abbott partnered with Women As One to create a robust agenda focused on leadership development in a safe, engaging and fun environment.
Jennifer Jones-McMeans, PhD
Divisional Vice President of Global Clinical Affairs at Abbott
Expand your reach and connect with a global network of highly skilled women cardiologists by advertising your job opportunities through Women As One. By posting your position with us, you gain direct access to our exclusive Talent Directory, which ensures that thousands of top-tier professionals worldwide see your opportunity. This strategic approach not only maximizes visibility but also fosters diversity, helping you attract exceptional talent while advancing inclusivity in cardiology.
We offer programming related to clinical education, professional development and award funding through the CLIMB, RISE and Awards programs.
These opportunities are only possible with the support and participation of our industry partners.
Through our programs, we provide resources for women cardiologists to build their careers and strengthen their skill sets while offering brand visibility to our industry partners.
Boston Scientific understands women are often excluded from opportunities in cardiology, from procedural leadership to industry collaboration. They are interested in being part of the solution, and as they prepared for TCT 2023, they wanted to connect with up-and-coming women thought leaders to support their awareness of ways of working with Boston Scientific. When they contacted Women As One, we knew we could help them do just that. to the Column block.
Women As One and Boston Scientific agreed that the best way to draw interest was to create a compelling program addressing the issue that had Boston Scientific looking for their future thought leaders in the first place: lack of industry opportunity.
We agreed to host a panel event in the Boston Scientific exposition hall booth at TCT 2023 to discuss their pipeline as a direct way of connecting with industry opportunities. Women As One worked with Boston Scientific to craft an agenda that would appeal to our community and sourced the Talent Directory to invite women matching Boston Scientific’s thought leadership strategy to participate.
Over 50 attendees participated in the breakfast event, with half staying afterward to connect with Boston Scientific staff. A junior cardiologist and former Women As One CLIMB participant we identified for the panel immediately caught Boston Scientific’s attention and has gone on to work with them further. Boston Scientific also now has ongoing access to a pool of qualified women to tap in to for future opportunities.
Separately, we can bring about change. Working together, we have no doubt we’re moving the needle for women in cardiology.
In early 2024, Medtronic made new strides in health equity when they completed their SMART Trial, which tested the efficacy of their transcatheter aortic valve replacement (TAVR) technology on small aortic annulus patients with symptomatic, severe native-aortic stenosis. As the condition disproportionately impacts women, it’s no wonder the trial enrolled an astonishing 87% women. This represented a huge opportunity to discuss Medtronic’s positive trial findings and to design trials aimed at improving women’s health. In advance of presenting their findings at ACC 2024, they were hoping to gain the insights of women cardiologists on how to position these messages among provider and patient communities and discuss future opportunities to engage more women in research. Medtronic didn’t want this step towards greater health equity to go unnoticed – and neither did we.
Medtronic didn’t need just any women physicians – they needed cardiologists with career experience, training, and access to patient perspectives that would make their insights indispensable. From our list of over 2,500 women physicians, we curated a focus group that discussed the SMART Trial design, leadership, and actionable strategies for achieving future success – all facilitated by our founder, Dr. Roxana Mehran.
Women As One brought 12 structural heart experts together with Medtronic leaders for a dynamic discussion on how to keep the momentum of the SMART Trial going. By partnering with Women As One, Medtronic ensured they have the foresight to make the SMART Trial results resonate and insights in to how they can continue to prioritize equitable trials and women’s health.
We are building the largest community of women cardiologists in our Talent Directory, which includes thousands of physicians in over 100 countries worldwide. We collect details about credentials, professional experiences and preferences to match talented women to professional opportunities. Our unique resource allows us to support the goals of external organizations and catalyzes improved equity in medicine.